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ABSTRACT
Methicillin
resistant
Staphylococcus
aureus (MRSA) infections constitute a global
health threat with high mortality and
morbidity rates; a problem aggravated by
antimicrobial resistance. Ficus thonningii
and Ficus natalensis have been used in
ethnomedicine for the treatment of bacterial
infections. Successive extraction was carried
out with hexane, ethyl acetate, and methanol
using a soxhlet apparatus. The crude extracts
obtained were screened for the presence of
phytochemicals using standard methods.
Vacuum liquid chromatography (VLC) of the
extracts was carried out. Clinical isolates
were verified with standard biochemical
assays and antibiogram was determined using
the disc diffusion method. The agar well
diffusion method was used to determine the
antibacterial activity of the extracts and
fractions. Minimum inhibitory concentration
(MIC)
and
minimum
bactericidal
concentration (MBC) was determined by
microbroth dilution method. Bactericidal
kinetics was determined using the viable
count technique. Phytochemicals present in
both plants include saponins, tannins,
flavonoids, cardiac glycosides, terpenoids,
steroids, alkaloids, and anthraquinones.

Extracts and fractions exhibited appreciable
activity on the test organisms. The ethyl
acetate extract and hexane extract of F.
thonningii and F. natalensis respectively
produced larger zones of inhibition that the
other extracts. The MICs of the crude extracts
from both plants ranged from 1.56 mg/mL to
50 mg/mL while the MBCs were between 12.5
mg/mL and ˃100 mg/mL. The fractions on the
other hand exhibited lower MICs and MBCs;
with MICs ranging between ≤0.039 mg/mL
and 3.125 mg/mL and MBCs between 1.525
mg/mL and 12.5 mg/mL. Bactericidal kinetics
showed a total kill at 24 hours at 10 mg/mL
and 5 mg/mL for both fractions.
INTRODUCTION
Staphylococcus aureus are frequently
implicated in invasive infections, skin and soft
tissue infections (SSTs), resulting in death in
some cases (Kourtis et al., 2019). MRSA is a
leading cause of bacteremia, nosocomial, bone,
and wound infections globally with a significant
mortality and morbidity rate (Lee et al., 2013;
Hassoun et al., 2017; Mikkaichi et al., 2019).
Use of plants for medical purposes is as old
as mankind. Plants have been reliable sources of
treatment and prophylaxis. Ethnomedicinal
information passed from generation to generation
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has provided scientists with hints on plants that
could be explored in the development of
therapeutic agents (Atanasov et al., 2015;
Ezekwesili-Ofili and Okaka, 2019). Medicinal
plants are plants whose part(s) contain substances
with therapeutic characteristics and can be used
as precursors for drug synthesis (EzekwesiliOfili and Okaka, 2019). With the advent and
spread of antimicrobial resistance, there has been
a growing interest in researching the therapeutic
potency of various medicinal plants. Medicinal
plants are paving a new approach to improved
medicine and are emerging as alternative
therapeutic options (Ali et al., 2016). About a
quarter of all Food and Drug Administration
(FDA) and/or the European Medical Agency
(EMA) approved drugs are plant based and over
the last 20 years, about a third of FDA approved
drugs are based on natural products and their
derivatives (Thomford et al., 2018).
The genus Ficus of the family Moraceae
(Mulberry) is commonly referred to as figs. It is
one of the most widely distributed genera of the
family (Lansky and Paavilainen, 2011); having
about 750 species (Chaudhary et al., 2012). Ficus
spp are very useful as they are used in traditional
medicine, as food plants, ornamental trees,
religious plants, fodder, fuel wood, hedges or
enclosures (Yinxian et al., 2014). There has been
an increasing interest in the genus Ficus because
of its chemical composition and potential health
benefits (Yadav et al., 2015; Tkachenko et al.,
2016).F. thonningii is also known as the bark
cloth fig or strangler fig (English), Chediya
(Hausa) and Odan (Yoruba). It is an evergreen
tree (about 6-21m tall) with a dense rounded to
spreading crown (Omoregie et al., 2015) mainly
distributed in the upland forests of tropical and
sub-tropical Africa (Dangarembizi et al., 2012).
It has been reported that the leaves are used to
treat diarrhoea, gonorrhoea, diabetes mellitus,
wounds, gingivitis, schistosomiasis, malaria,
liver disorders, disease conditions associated
with jaundice, bronchitis and urinary tract
infections (Ahur et al., 2010; Dangarembizi et
al., 2012; Falade et al., 2014).
F. natalensis commonly referred to as natal
fig (English), ogunke (Yoruba) is a small tree

native to Southern and Western Africa. It is a
monoecious evergreen epiphytic or terrestrial
tree. Its leaves are 2.5-10 cm long and 1-8 cm
wide (Burrows and Burrows, 2003; Oyen, 2011).
In traditional medicine, the leaves are used in
treating malaria, wounds, ulcers and warts
(Oyen, 2011).
We therefore aimed to investigate the
susceptibility of extracts and fractions of leaves
of F. thonningii and F. natalensis on MRSA.
MATERIALS AND METHODS
Plant collection and preparation. The leaves of
Ficus thonningii and Ficus natalensis were
collected from Arulogun junction, Ojoo, and the
Botanical Garden, University of Ibadan, and
were authenticated at the Forestry Research
Institute of Nigeria (FRIN), Ibadan with voucher
numbers FHI: 112235 for Ficus natalensis and
FHI: 112351 for Ficus thonningii. The leaves
were air-dried under shade at about 29oC in
October. The dried leaves were pulverised,
weighed and stored in airtight containers.
Plant Extraction and Fractionation. Pulverised
leaves (1050g of F. thonningii and 650g of F.
natalensis) were successively extracted with
solvents of varying polarity (hexane, ethyl
acetate and methanol) using a soxhlet apparatus
(GSC International, Inc. MO, USA). The crude
extracts were evaporated to dryness using a
rotary vacuum evaporator (Heidolph Laborota,
Germany), weighed and stored in a freezer at 4oC
for further analysis. Ethyl acetate extract for F.
thonningii (40g) and hexane extract for F.
natalensis (12g) were subjected to vacuum liquid
chromatography (VLC). VLC was carried out
using a modified procedure as described: the
extracts were separately absorbed with silica gel
(60-200 mesh size) and allowed to dry. Filter
paper (Whatman no 1) was placed on the internal
surface of the Buchner funnel, after which silica
gel was poured into the funnel. A layer of cotton
wool was placed on top of the silica gel, the dried
extract was loaded onto the funnel and a filter
paper was placed over the extract. Hexane,
hexane/chloroform
gradient,
chloroform,
chloroform/ethyl acetate gradient, ethyl acetate,
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ethyl acetate/methanol gradient and methanol
were used as eluents. Thirteen fractions each
were collected for both plants. On the basis of
TLC profiling, fractions were pooled based on
their TLC profiles to yield seven fractions (FTE
1-7) for F. thonningii and six fractions (FNH 16) for F. natalensis. Antimicrobial assay was
carried out to determine active fractions.
Phytochemical screening. The crude extracts
obtained from both plants were screened for the
presence of secondary metabolites according to
standard procedures (Vinoth, 2012).
Test organisms. Clinical isolates of MRSA from
different sources (wounds, blood, and urine)
were obtained from the Medical Microbiology
Laboratory, University College Hospital, Ibadan.
All isolates were screened for purity and
identified by biochemical tests. Isolates positive
for both slide and tube coagulase test were
identified as S. aureus. Methicillin-resistance
was determined using cefoxitin disc according to
Clinical Laboratory Standards Institute (CLSI,
2018). Isolates were maintained in slants of
nutrient agar at 4oC. S. aureus strain ATCC
29213 was used as a reference. Antibiotic
sensitivity pattern of clinical isolates was
determined by standard disc diffusion method
according to the standards prescribed by Clinical
and Laboratory Standards Institute (CLSI, 2018).
Gram staining. A sterile wire-loop was used to
transfer a colony of microbial culture to a loopful
of water on a clean glass slide. A thin smear was
made on the glass slide and air dried. The smear
was heat fixed and stained with crystal violet for
30 seconds and rinsed with distilled water,
Lugol’s iodine was added as a mordant for 60
seconds and rinsed off. Ethanol (95%) was added
for 45 seconds to decolorize and the smear was
counterstained with safranin for 30 seconds and
rinsed with distilled water. The slide was airdried, a drop of immersion oil was added and the
slide was viewed under the microscope at x100
objective lens.
Selective plating on blood agar. Blood agar
plates were prepared by mixing 1 mL of freshly
collected human blood with 19 mL of molten

sterile nutrient agar at 45oC. The mixture was
poured and allowed to set. The surface was dried
and streaked with the 18 h broth culture of the
organism and incubated at 24 h at 37oC. The
plates were observed for isolated, round golden
yellow colonies with surrounding haemolysis.
Catalase test. A sterile wireloop was used to pick
a colony of the isolate to make a smear on a glass
slide containing 2-3 drops of 3% hydrogen
peroxide. Production of gas bubbles indicated a
positive reaction.
Slide coagulase test. On a clean grease free glass
slide, part of a colony was emulsified and 10 µL
of plasma was added and was observed for the
presence of agglutination which indicates a
positive reaction.
Tube coagulase test. Isolates were incubated in
Mueller Hinton broth at 37 oC for 24 h. In a sterile
glass test tube, 0.2ml of the overnight broth
culture was added to 0.5ml citrated human
plasma and mixed gently. The test tubes were
incubated at 37 oC and observed for coagulation
at the 1 h, 2 h, 4 h and 24 h. Formation of a firm
opaque clot which remains in the place when the
tube is tilted on its side was considered positive.
In vitro antimicrobial screening of plant extracts.
Antimicrobial screening was conducted using
agar well diffusion as described by Coker and
Onu, 2019. The extracts were dissolved in
methanol to give varying concentrations.
Bacterial suspension adjusted to 0.5 McFarland
standard was used to inoculate Mueller Hinton
plates with the aid of sterile cotton tipped
applicator. Equidistant wells of about 8 mm were
bored with a cork borer in the set agar. The holes
were filled with the appropriate concentration (25
mg/mL and 100 mg/mL) of the prepared extracts.
The plates were left on the bench for an hour to
allow the extracts diffuse into the agar before
incubating at 37oC for 24 h. Zones of inhibition
were measured after the incubation period from
which the antibacterial activity of the crude
extracts against the test organisms was
determined. Vancomycin (30 µg/mL) was used
as standard drug control (positive control) and
methanol as negative control. The experiment
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was done in duplicates.
Determination of MIC and MBC. Minimum
inhibitory concentration (MIC) of the extracts
and fractions was determined by the
microdilution broth method described by Kuete
et al. (2008). The extracts and fractions were
serially diluted in Mueller Hinton broth (MHB)
to obtain a concentration range between 0.391100 mg/mL (extracts) and 0.391-12.5 mg/mL
(fractions). Each well contained 100 µL of each
concentration, 95 µL of MHB and 5 µL of
bacterial suspension adjusted to 0.5 McFarland
standard. Wells containing 195 µL of MHB and
5 µL of bacterial suspension served as fertility
control. Vancomycin was used as the control
drug. The plates were covered and incubated at
37 oC for 24 h. After which about 50 µL of
tetrazolium salt (2 mg/mL) was added to each of
the wells at 37 oC for 30 minutes. A purple
coloration indicated the presence of viable
bacteria. The lowest concentration that prevented
this change was taken as the MIC. To determine
the MBC, wells showing no visible growth were
streaked on Mueller Hinton agar plate using a
sterile loop and incubated at 37 oC for 24 h. The
lowest concentration showing no bacterial
growth was taken as the MBC.
Bactericidal kinetics. Bactericidal kinetics was
carried out on the most active fraction from both
plants using a modified procedure described by
Idowu and Idowu (2014). Overnight culture of
the most sensitive isolate was made in 5 mL of
nutrient broth. 0.1 mL of the culture was used to
inoculate 3.9 mL of nutrient broth containing 1
mL of fraction at varying concentrations (10
mg/mL, 5 mg/mL, 2.5 mg/mL). Serial dilutions
was made from this mixture containing culture,
broth and fraction and 0.1 mL of the 10-3 dilutions
was used to inoculate a freshly prepared nutrient
agar plate at time intervals 0, 0.5, 1, 2, 4, 6 and
24 h. Plates were incubated at 37 oC for 24 h.
Colony count was determined and a graph of log
of CFU/mL was plotted against time. A control
broth was set up without any added extract.
RESULTS
Qualitative phytochemical screening of
extracts of both plants (Table 2) showed the

presence of alkaloids, saponins, tannins,
flavonoids, cardiac glycosides, terpenoids,
steroids and anthraquinones in at least one of the
extracts.
Despite exhibiting multi-drug
resistance as shown in Table 1, isolates proved
susceptible to the crude extracts and fractions of
both plants. Zones of inhibition ranging from 10
mm to 20 mm across were recorded from the
crude extracts (Table 3). However, a few isolates
had zones of <10mm or showed no zone of
inhibition. The highest zone of inhibition
recorded was 20mm at 100 mg/mL for the hexane
extract of F. natalensis and the ethyl acetate
extract for F. thonningii. The MIC recorded of
the crude extracts from both plants ranged
between 1.5625mg/mL and 50mg/mL while the
MBC ranged between 12.5 mg/mL and
˃100mg/mL (Table 4). The ethyl acetate extract
of F. thonningii had the lowest MIC values, the
MIC values ranged between 3.125 mg/mL to 25
mg/mL while the MBC of the isolates were either
at 25 mg/mL or 50 mg/mL. Hexane extract of F.
natalensis had lower MICs ranging between
1.5625mg/mL and 25mg/mL. For most isolates,
the MBC was either 4X the MIC or 6X the MIC.
Fractionating the most active extracts of both
plants yielded fractions with lower MIC and
MBC values than the crude extracts (Tables 5 and
6). The MICs of the fractions ranged between
≤0.039 mg/mL and 3.125 mg/mL and MBCs
between 1.525 mg/mL and 12.5 mg/mL. Figs 2
and 3 show the bactericidal action of fractions
FTE3 and FNH6 respectively. Initially, growth
was observed in both fractions between 0 and 1
hour, after which killing progressed slowly over
a period of 24 h. Across all concentrations for
both fractions significant reduction was observed
after 4 h. A total kill was observed at
concentrations 10 mg/mL and 5 mg/mL for both
fractions after 24 h of exposure. At 2.5 mg/mL, a
few growth colonies were observed after 24 h of
exposure for both fractions, notwithstanding, the
initial growth observed at 0 hour had greatly
reduced. The control broth showed progressive
increase in growth colonies over the 24 h time
frame.
Comparing the activity of extracts and
fractions from both plants, the activity of extracts
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and fractions from F. natalensis showed better
activity on the isolates.
DISCUSSION
MRSA is a common nosocomial pathogen,
which is gradually being associated with
community associated infections with significant
mortality and morbidity (Osinupebi et al., 2018;
Lakhundi and Zhang, 2018; Mikkaichi et al.,
2019). According to Lee et al. (2004), MRSA is
usually resistant to commonly used antibiotics
such
as
aminoglycosides,
macrolides,
chloramphenicol,
fluroquinolones,
cephalosporins,
ampicillin-sulbactam,
carbapenems, beta lactams and derivatives.
Phytochemicals occur naturally in medicinal
plants; they are primary (examples, proteins,
chlorophyll, common sugar) and secondary
compounds (terpernoids, alkaloids, saponins,
flavonoids) occurring naturally in plants
(Wadood et al., 2013; Mudasar et al., 2016).
Alkaloids, saponins, tannins, anthraquinones,
and flavonoids are known to have activity against
several pathogens (Usman et al., 2009; Shalini
and Sampathkumar, 2012). Alkaloids have been
known to show good antibacterial activity against
Gram positive bacteria (Karou et al., 2005;
Mabhiza et al., 2016; Gurrapu and Mamidala,
2017). Terpenoids have been isolated from
various plants and they have shown in vitro
antimicrobial activities against both Gram
positive and Gram negative bacteria (Ludwiczuk
et al., 2016). The phytochemical screening of F.
thonningii leaves reported by Coker et al. (2015)
supports the phytochemical screening reported in
this study. While the methanol extract contained
all phytochemicals tested for, the ethyl acetate
and hexane extract lacked some of the
phytochemicals. Usman et al. (2009) had a
similar finding; some of the phytochemicals
present in the methanol crude extract were absent
in the n-butanol and residual aqueous extracts of
F. thonningii stem bark.
The antibacterial activity of the extracts can
be attributed to the presence of phytochemicals
present in the extracts. Phytochemicals such as
flavonoids, tannins, alkaloids, terpenoids etc
have been associated with combating
antimicrobial resistance in organisms (Neog et

al., 2013; Debalke et al., 2018). F. thonningi has
been proven to have antibacterial activity on both
Gram positive and Gram negative pathogens
(Usman et al., 2009). It was however expected
that the methanol extract in this study will exhibit
a better activity based on the various
phytochemicals it contained, however, it showed
the least activity with some of isolates having no
zone of inhibition. This observation is similar to
reports by Usman et al. (2009). They reported
better activity with the n-butanol and aqueous
extracts of F. thonningii stem bark than with the
methanol extract despite the methanol extract
indicating presence of more phytochemicals than
the other extracts. The findings on the
antibacterial activity of the crude extracts of F.
thonningii infer that the bioactive components
responsible for the activity on MRSA are
moderately polar. The appreciable antibacterial
activity observed with the hexane extract is in
line with the activity observed with the petroleum
ether extract (Ajaib et al., 2016). However, the
zones of inhibition observed against S. aureus are
wider compared to the diameter of zones of
inhibition observed in this study. Comparable
zones of inhibition for hexane, ethyl acetate and
methanol extracts were reported by Coker and
Oaikhena (2020). In comparison to the inactivity
of the hexane, ethyl acetate and methanol extracts
of F. natalensis on MRSA reported by Sheyin et
al. (2018), the extracts in this study exhibited
better activity against MRSA.
The MICs of the crude extracts of F.
thonningii and F. natalensis were between 1.56
mg/mL to 50 mg/mL while the MBCs ranged
from 12.5 mg/mL and ˃100 mg/mL. We
observed lower MICs (≤0.039 mg/mL and 3.125
mg/mL) and MBCs (1.525 mg/mL and 12.5
mg/mL) for active fractions, implying that the
fractions contained more active constituents than
the crude extracts. Usman et al (2009) reported
MIC as low as 5 mg/mL of methanol stem bark
of F. thonningi on S. aureus and Ajaib et al.
(2016) recorded an MIC as low as 0.625 mg/mL
of F. natalensis on S. aureus. Sheyin et al. (2018)
recorded no MIC of F. natalensis on MRSA. It
has been proposed that plant extracts with MIC
values ≤0.5 mg/mL are strong inhibitors, those
56
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with MIC between 0.6 mg/mL and 1.5 mg/mL
are moderate inhibitors and extracts with MICs
≥1.6 mg/mL are weak inhibitors (Aligiannis et
al., 2001). Based on this proposition on MIC
threshold, the inhibitory activity of the fractions
is better than that of the crude extracts, this
implies that with further purification of the active
fractions, fractions with lower MICs and strong
inhibitory activity can be obtained.
Bactericidal kinetics showed a concentration
dependent activity of the fractions against
MRSA. The bactericidal kinetics of the fractions
suggested that the mechanism of action of the
extracts may be cidal rather than static or
inhibitory.

CONCLUSIONS
F. thonningii and F. natalensis have shown
potent antimicrobial activity against MRSA. The
secondary metabolites contained in the plants
may be responsible for the observed antibacterial
activity. The activity of the extracts and fractions
on the test isolates despite being resistant to
multiple antibiotics showed that the plants have
the potential to be alternative options for
treatment of drug-resistant bacterial infections
and could serve as precursors for production of
drugs against MRSA infections.

Figure 2: Bactericidal kinetics of ethyl acetate fraction
FTE 3 on MRSA I showing gradual kill in response to
the fraction concentrations over 24 hours.

Figure 1: Graph showing the sensitivity of the test
organisms to different antibiotics. CAZ- ceftazidime,
CRX- cefuroxime, GEN- gentamicin, CTR- ceftriaxone,
ERY- Erythromycin, CXC- cloxacin, OFL- ofloxacin,
AUG- augumentin, FOX- cefoxitin. R- resistant, Iintermediate, S- sensitive.

Figure 3: Bactericidal kinetics of hexane fraction FNH5
on MRSA I showing gradual kill of the organism in
response to the fraction concentrations over 24 hours.
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Table 1 Antibiotic sensitivity patterns of the test organisms

* CAZ- ceftazidime, CRX- cefuroxime, GEN- gentamicin, CTR- ceftriaxone, ERY- Erythromycin, CXC- cloxacin, OFLofloxacin, AUG- augumentin, FOX- cefoxitin.
R- resistant, I- intermediate, S- sensitive.

Table 2 Qualitative phytochemical screening of leaf extracts of Ficus thonningii and Ficus natalensis
Phytochemical
Saponins
Tannins
Flavonoids
Cardiac glycosides
Terpenoids
Steroids
Alkaloids
Anthraquinones

Hexane extract Ethyl acetate extract
Ft
Fn
Ft
Fn
+
+
++
+
++

++
++
+

++
+
++
+
+
+

+
+
+
+
+

Methanol extract
Ft
Fn
+
++
++
++
+
+
+
+

+
+
+
+
+
+
+
+

* Ft; Ficus thonningii, Fn; Ficus natalensis, -; absence of phytochemical; +; presence of phytochemical,
++; abundance of phytochemical.
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Table 3 Antibacterial activity of crude extracts of Ficus thonningii and Ficus natalensis on test isolates

* Ft; F. thonningii, Fn; F. natalensis, Van- vancomycin MRSA; methicillin-resistant Staphylococcus aureus -; no zone of inhibition
Table 4. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of crude extracts of Ficus thonningii and Ficus natalensis on
test isolates on test isolates.

* MRSA; methicillin-resistant Staphylococcus aureus, -; no zone of inhibition, Ft; F. thonningii, Fn; F. natalensis
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Table 5 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of active fractions obtained from VLC
fractionation of crude ethyl acetate extract of Ficus thonningii on selected isolates.

*FTE; F. thonningii ethyl acetate fraction, MRS; Methicillin-resistant Staphylococci, MRSA- methicillin-resistant Staphylococcus aureus
Table 6. MIC and MBC of active fractions obtained from VLC fractionation of crude hexane extract of Ficus natalensis on selected isolates.

* FNH; F. natalensis hexane fraction, MRSA- methicillin- resistant Staphylococcus aureus
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